Julianne Bruno, Chief Operating Officer at CRISPR Therapeutics AG (CRSP), sold 2,586 shares at $42.42 ($110K) on 2025-03-11, disclosed to the SEC on 2025-03-12.
Open-market sale of $110k CRSP by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.42 | 1,198 | $51K | 46.3% |
| 2 | $42.42 | 1,198 | $51K | 46.3% |
| 3 | $43.32 | 190 | $8K | 7.5% |
| Total | $42.49 avg | 2,586 | $110K | 100% |
| Filing → |
| CRSP | SELL | 2024-06-24 | $378K | — | Filing → |